Notice of Information: NICHD to issue a Research Opportunity Announcement to support Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays - ACT ENDO (OTA Clinical Trial Optional)

The National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) plans to issue a Research Opportunity Announcement (ROA) to invite applications from eligible organizations to develop, advance, and/or validate new devices, biomarkers, and/or methods or repurpose existing devices for non-invasive diagnosis of endometriosis. The ROA will consist of two stages: an open call for pre-applications, followed by an invitation-only stage to apply to the "Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO)" ROA to be offered in the summer of 2024. Participation in the Stage 1 pre-application step is required to receive an invitation to Stage 2, but no awards will be made in response to the pre-application. Awards under Stage 2 will be issued as Other Transactions Agreements (OTAs), which involve active NIH program management.

This opportunity is not set-aside for any specific business size or type. The applicable NAICS and PSC codes are not provided in the pre-solicitation notice. The notice does not mention any potential incumbents or current contractors, award values, budget ranges, or specific quantities of goods or services required. The pre-solicitation notice is focused on providing high-level information about the upcoming ROA and the two-stage application process.